Vivek Subbiah: Live news segment on cutting-edge oncology progress with Erika Hamilton

Vivek Subbiah shared a post on LinkedIn:

”Bright and early!

Just recorded a live news segment on cutting-edge oncology progress, team tagging with world-renowned breast cancer expert Dr. Erika Hamilton for NewsNation.”

Source: Vivek Subbiah/LinkedIn

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.